Source: BEFREE
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phospholipase C epsilon 1 | 0.572 | 0.654 | 5.7E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 3 | 2014 | 2014 | ||||||||
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | |||||||||
|
vascular endothelial growth factor C | 0.459 | 0.769 | 0.50 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 2 | 2014 | 2014 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2014 | 2014 | ||||||||
|
pyruvate kinase M1/2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2016 | 2017 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2008 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2015 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2007 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2012 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.040 | None | 0.750 | 4 | 2 | 2014 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2000 | 2018 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2009 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.842 | 19 | 4 | 1994 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2009 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.080 | None | 0.875 | 8 | 1 | 2007 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2006 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 1.000 | 10 | 1 | 2004 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2001 | 2019 | ||||||||
|
sarcoglycan beta | 0.656 | 0.346 | 9.6E-07 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2012 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 2015 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2015 | 2019 |